Gastrointestinal Diseases  >>  Inlyta (axitinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
NCT00219557 / 2005-000053-30: AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

Completed
2
111
Canada, US, Europe
Gemcitabine, AG-013736
Pfizer
Pancreatic Neoplasms
03/08
03/08
NCT00615056 / 2007-006283-30: A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

Checkmark Data-ASCO
Feb 2011 - Feb 2011: Data-ASCO
Checkmark Data - CRC
Feb 2011 - Feb 2011: Data - CRC
Completed
2
171
Japan, US, Canada, Europe, RoW
Bevacizumab (avastin), FOLFIRI (Irinotecan, leucovorin, 5-fluorouracil [5FU]), AG-013736 (axitinib), FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU]), FOLFIRI (irinotecan, leucovorin, 5-fluorouracil [5FU])
Pfizer
Colorectal Neoplasms
03/11
04/12
NCT01210495 / 2010-021590-37: Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

Checkmark ESMO 2014
Sep 2014 - Sep 2014: ESMO 2014
Completed
2
224
Japan, US, Europe, RoW
Axitinib (AG-013736), Best Supportive Care, Placebo
Pfizer
Hepatocellular Carcinoma
03/14
12/16
NCT01483638 / 2011-002384-16: Axitinib as Maintenance Treatment in Patients With Metastatic CRC

Terminated
2
84
Europe
axitinib, placebo
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Colorectal Carcinoma
09/15
09/15
NCT01273662: Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma

Completed
2
45
RoW
AG-013736, Axitinib
National Taiwan University Hospital, Tri-Service General Hospital, Taipei Veterans General Hospital, Taiwan
Hepatocellular Carcinoma
03/16
12/16
NCT01352728: Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ESMO 2014
Sep 2014 - Sep 2014: ESMO 2014
Completed
2
50
RoW
Axitinib
Chinese University of Hong Kong
Hepatocellular Carcinoma
06/18
06/18
NCT00460603: Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

Checkmark
Apr 2013 - Apr 2013: 
Checkmark Data-ASCO
Feb 2011 - Feb 2011: Data-ASCO
Completed
1/2
187
US
bevacizumab, AG-013726, AG-013736 (axitinib)
Pfizer
Colorectal Neoplasms
04/12
11/12

Download Options